Table 5.
Results from Cox regression analysis of factors important for cancer-specific survival in 149 patients with clear cell renal cell carcinoma, adjusted for age, gender, tumor size (mm), tumor grade, tumor stage, and HIF-1α, HIF-2α, and HIF-3α nuclear and cytoplasmic expression levels, respectively.
Predictor | Unadjusted | Adjusteda | ||||
---|---|---|---|---|---|---|
RR | 95% CI | P | RR | 95% CI | P | |
Age continous | 0.998 | 0.985–1.012 | 0.821 | 0.984 | 0.958–1.011 | 0.242 |
Female vs. Male | 0.832 | 0.611–1.134 | 0.244 | 1.721 | 0.954–3.106 | 0.071 |
Tumor Size (mm) | 1.013 | 1.010–1.017 | < 0.001 | 1.006 | 0.998–1.014 | 0.114 |
Grade (1, 2 vs. 3,4) | 2.352 | 1.928–2.868 | < 0.001 | 1.511 | 1.108–2.059 | 0.009 |
Stage (I, II vs. III,IV) | 8.365 | 5.659–12.366 | < 0.001 | 8.543 | 4.183–17.447 | < 0.001 |
HIF-1α-Nuclear | 2.106 | 1.306–3.397 | 0.002 | 1.919 | 0.864–4.261 | 0.109 |
HIF-1α-Cytoplasm | 1.428 | 0.897–2.275 | 0.133 | 1.010 | 0.805–1.267 | 0.930 |
HIF-2α-Nuclear | 0.988 | 0.619–1.576 | 0.959 | 0.956 | 0.485–1.887 | 0.898 |
HIF-2α-Cytoplasm | 1.039 | 0.633–1.705 | 0.881 | 0.891 | 0.423–1.875 | 0.760 |
HIF-3α-Nuclear | 1.872 | 1.165–3.009 | 0.010 | 1.242 | 0.628–2.458 | 0.533 |
HIF-3α-Cytoplasm | 1.635 | 1.028–2.600 | 0.038 | 1.504 | 0.740–3.058 | 0.260 |
Note: CI, confidence interval; RR, risk ratio; Tumor Size, tumor size in mm; Grade, tumor grade; Stage, TNM tumor stage; Significant P-values are given in bold.